A Prospective Study of Eplerenone in the Treatment of Patients with Glomerulonephritis.

Biomedicines · 2023 · PMC10741749 · PMID 38137561

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Moreover, patients who received eplerenone maintained stable kidney function after 12 months, while those who received conservative treatment alone showed a trend of decline in eGFR.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.